Feasibility and acceptability of using wireless cardiac monitoring before transcatheter aortic valve implantation (TAVI): A pilot study.

Abstract

Currently, all transcatheter aortic valve implantation (TAVI) patients treated at Epworth Richmond are admitted the day before their procedure for cardiac monitoring to identify undiagnosed arrhythmias that may increase the risk of requiring a permanent pacemaker. These patients also undergo a routine pre operative full blood test, chest X Ray and ECG. Use of remote cardiac monitoring devices from the patient’s home may increase the efficiency of workflows, reduce bed usage in coronary care, and improve bed capacity, ultimately increasing hospital revenue. However, presently, the use of such devices has been inadequately tested. If the data quality meets the requirements of treating interventional cardiologists, this could potentially eliminate the need for patients to be admitted 24 hours prior to their scheduled TAVI procedure.